Skip to main content
Journal cover image

Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure.

Publication ,  Journal Article
Curtis, LH; Mi, X; Qualls, LG; Check, DK; Hammill, BG; Hammill, SC; Heidenreich, PA; Masoudi, FA; Setoguchi, S; Hernandez, AF; Fonarow, GC
Published in: Am Heart J
June 2013

BACKGROUND: Aldosterone antagonist therapy is recommended for selected patients with heart failure and reduced ejection fraction. Adherence to therapy in the transition from hospital to home is not well understood. METHODS: We identified patients with heart failure and reduced ejection fraction who were ≥65 years old, eligible for aldosterone antagonist therapy, and discharged home from hospitals in the Get With the Guidelines-Heart Failure registry between January 1, 2005, and December 31, 2008. We used Medicare prescription drug event data to measure adherence. Main outcome measures were prescription at discharge, outpatient prescription claim within 90 days, discontinuation, and adherence as measured with the medication possession ratio. We used the cumulative incidence function to estimate rates of initiation and discontinuation. RESULTS: Among 2,086 eligible patients, 561 (26.9%) were prescribed an aldosterone antagonist at discharge. Within 90 days, 78.6% of eligible patients with a discharge prescription filled a prescription for the therapy, compared with 13.0% of eligible patients without a discharge prescription (P < .001). The median medication possession ratio was 0.63 over 1 year of follow-up. Among 634 patients who filled a prescription within 90 days of discharge, 7.9% discontinued therapy within 1 year. CONCLUSION: Most eligible patients were not prescribed aldosterone antagonist therapy at discharge from a heart failure hospitalization. Eligible patients without a discharge prescription seldom initiated therapy as outpatients. Most patients who were prescribed an aldosterone antagonist at discharge filled the prescription within 90 days and remained on therapy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

June 2013

Volume

165

Issue

6

Start / End Page

979 / 986.e1

Location

United States

Related Subject Headings

  • United States
  • Survival Rate
  • Stroke Volume
  • Retrospective Studies
  • Registries
  • Mineralocorticoid Receptor Antagonists
  • Medication Adherence
  • Medicare
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Curtis, L. H., Mi, X., Qualls, L. G., Check, D. K., Hammill, B. G., Hammill, S. C., … Fonarow, G. C. (2013). Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure. Am Heart J, 165(6), 979-986.e1. https://doi.org/10.1016/j.ahj.2013.03.007
Curtis, Lesley H., Xiaojuan Mi, Laura G. Qualls, Devon K. Check, Bradley G. Hammill, Stephen C. Hammill, Paul A. Heidenreich, et al. “Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure.Am Heart J 165, no. 6 (June 2013): 979-986.e1. https://doi.org/10.1016/j.ahj.2013.03.007.
Curtis LH, Mi X, Qualls LG, Check DK, Hammill BG, Hammill SC, et al. Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure. Am Heart J. 2013 Jun;165(6):979-986.e1.
Curtis, Lesley H., et al. “Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure.Am Heart J, vol. 165, no. 6, June 2013, pp. 979-986.e1. Pubmed, doi:10.1016/j.ahj.2013.03.007.
Curtis LH, Mi X, Qualls LG, Check DK, Hammill BG, Hammill SC, Heidenreich PA, Masoudi FA, Setoguchi S, Hernandez AF, Fonarow GC. Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure. Am Heart J. 2013 Jun;165(6):979-986.e1.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

June 2013

Volume

165

Issue

6

Start / End Page

979 / 986.e1

Location

United States

Related Subject Headings

  • United States
  • Survival Rate
  • Stroke Volume
  • Retrospective Studies
  • Registries
  • Mineralocorticoid Receptor Antagonists
  • Medication Adherence
  • Medicare
  • Male
  • Humans